Rotaviruses and Rotavirus Vaccines: Special Issue Editorial by John T. Patton, Ulrich Desselberger

Get full text

Diarrheal Diseases Hospitalization in Yemen before and after Rotavirus Vaccination by Mohammed Amood AL-Kamarany, Lina Al-Areqi, Abulatif Mujally, Fawzya Alkarshy, Arwa Nasser, Aisha O. Jumaan

“…Rotarix™ ® rotavirus vaccine is currently licensed for infants in Yemen and was introduced in 2012. …”
Get full text

Indirect protection from rotavirus vaccines: a systematic review by Tyler Chavers, Jordan Cates, Eleanor Burnett, Umesh D. Parashar, Jacqueline E. Tate

“…Introduction Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden.Methods This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates.Results We identified 71 studies published between 2009 and 2022 that provided 399 estimates of indirect protection from rotavirus vaccine. …”
Get full text

Impact of rotavirus vaccination on diarrheal disease burden of children in South America by Tanmoy Bose, Ray Borrow, Peter D Arkwright

“…Overall, data suggest that rotavirus vaccination has reduced rotavirus deaths by 15–50% in various South American countries. …”
Get full text

Rotavirus vaccine coverage, completion, and compliance: A systematic literature review by Halima Tahrat, Ali Munir, Federico Marchetti

“…Rotavirus, a leading cause of severe acute gastroenteritis in children, is largely preventable through immunization with two internationally licensed oral rotavirus vaccines (RVVs) included in national programs across over 100 countries. …”
Get full text

Impact of rotavirus vaccination in Malawi from 2012 to 2022 compared to model predictions by Virginia E. Pitzer, Latif Ndeketa, Ernest O. Asare, Daniel Hungerford, Benjamin A. Lopman, Khuzwayo C. Jere, Nigel A. Cunliffe

“…Our mathematical models provide a validated platform for assessing strategies to improve rotavirus vaccine impact in low-income settings.…”
Get full text

The Apparent Lack of the Risk of Intussusception Immediately After Rotavirus Vaccination Among Japanese Infants by Wakako Kikuchi, Atsuko Noguchi, Yoko Sato, Yuuki Konno, Akira Komatsu, Satoru Tandai, Wataru Kikuchi, Shinobu Miura, Hiroshi Fukaya, Tomoaki Ohata, Hiroo Noguchi, Kenichi Matsuno, Hisayuki Tsukahara, Daiki Kondo, Masaki Komatsu, Masamichi Tamura, Hiromi Koizumi, Toyoko Nakagomi, Osamu Nakagomi, Tsutomu Takahashi

Subjects: “…rotavirus vaccines…”
Get full text

Intussusception associated with rotavirus vaccination in a 2-month-old infant: A case report by Shu-Wei Hu, Min-Yung Kuo, Hueng-Chuen Fan

Subjects: Get full text

Coverage and distributional benefit–cost of rotavirus vaccine in Uganda: an analysis of routine health facility aggregated data by Rornald Muhumuza Kananura, Gatien de Broucker, Anthony Ssebagereka, Aloysius Mutebi, Elizabeth Ekirapa Kiracho, Bryan Patenaude

“…Abstract Introduction Owing to the lack of local cost and clinical effectiveness data in sub-Saharan Africa, economic evaluations of the rotavirus vaccine are still limited in the region. In this study, we utilize different data sources, including aggregated routine health information system data to examine the net benefits of the rotavirus vaccine in Uganda. …”
Get full text

Adverse Events of the BCG (Bacillus Calmette–Guérin) and Rotavirus Vaccines in a Young Infant with Inborn Error of Immunity by Suleiman Al-Hammadi, Najla S. Alkuwaiti, Ghassan A. Ghatasheh, Huda Al Dhanhani, Hiba M. Shendi, Abdulghani S. Elomami, Farida Almarzooqi, Abdul-Kader Souid

“…The Bacillus Calmette–Guérin (BCG) and rotavirus vaccines are live-attenuated preparations. In the United Arab Emirates, these products are universally administered to the young infants. …”
Get full text

Measuring the Vaccine Success Index: A Framework for Long-Term Economic Evaluation and Monitoring in the Case of Rotavirus Vaccination by Baudouin Standaert, Marc Raes, Olivier Ethgen, Bernd Benninghoff, Mondher Toumi

“…Here, an example is provided by a 15-year assessment of the rotavirus vaccination program in Belgium (RotaBIS study spanning 2005 to 2019 across 11 hospitals). …”
Get full text

Measurement of coverage, compliance and determinants of uptake in a publicly funded rotavirus vaccination programme: a retrospective cohort study by Lawrence W Svenson, Ellen Rafferty, Xiaoyan Guo, Bruce McDonald, Shannon Elizabeth MacDonald

“…Objectives In June 2015, Alberta, Canada instituted a universal publicly funded rotavirus vaccination programme (Rotarix, RV1), with vaccine doses scheduled for 2 and 4 months of age. …”
Get full text

Rotavirus Vaccination Protects Against Diabetes Mellitus Type 1 in Children in Developed Countries: A Systematic Review and Meta-Analysis by Chrysoula Kosmeri, Achilleas Klapas, Nikolas Evripidou, Evanthia Kantza, Anastasios Serbis, Ekaterini Siomou, Fani Ladomenou

Subjects: “…rotavirus vaccine…”
Get full text

Correction: Measurement of coverage, compliance and determinants of uptake in a publicly funded rotavirus vaccination programme: a retrospective cohort study

Get full text

Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach. by Katayi Mwila-Kazimbaya, Samuel Bosomprah, Obvious Nchimunya Chilyabanyama, Caroline Cleopatra Chisenga, Mwelwa Chibuye, Natasha Makabilo Laban, Michelo Simuyandi, Bert Huffer, Miren Iturriza-Gomara, Robert K M Choy, Roma Chilengi

“…Immune responses to oral rotavirus vaccines (Rotarix, Rotavac, and Rotavac 5D) as well as a parenteral rotavirus vaccine (trivalent P2-VP8) were also measured and machine learning using the lasso approach was then applied to investigate any associations between immune responses and environmental enteric dysfunction, systemic inflammation, and growth hormone resistance biomarkers.…”
Get full text

Epidemiology of Rotavirus Diarrhoea in Children and Adults Presenting with Acute Gastroenteritis at a Tertiary Care Hospital in Northern India: A Cross-sectional Study by Aarsi Aarsi, Loveena Oberoi, Shailpreet Kaur Sidhu, Manmeet Kaur Sodhi, Tavishi Oberoi

Subjects: Get full text

Determinants of Rotavirus Vaccine Acceptance in an Area of Southern Italy with Low Vaccination Coverage: A Case-Control Study by the Health Belief Model Questionnaire by Davide Anzà, Massimiliano Esposito, Giorgio Bertolazzi, Alessandra Fallucca, Carlo Genovese, Gabriele Maniscalco, Andrea D. Praticò, Tiziana Scarpaci, Ermanno Vitale, Vincenzo Restivo

“…The introduction of Rotavirus vaccines (RVV) has markedly reduced RV-related childhood deaths, especially in Europe, where substantial reductions in hospitalizations and disease prevalence have been observed. …”
Get full text

Population impact and effectiveness of sequential 13-valent pneumococcal conjugate and monovalent rotavirus vaccine introduction on infant mortality: prospective birth cohort studies from Malawi by Anthony Costello, Neil French, Charles Mwansambo, Ellen Heinsbroek, Naor Bar-Zeev, Amelia Crampin, Nigel Cunliffe, Sonia Lewycka, Carina King, James Beard, Tambosi Phiri, Hazzie Mvula, Dan Hungerford, Jennifer Verani, Cynthia Whitney, Rob Heyderman, Osamu Nakagomi, Jacqueline E Tate, Umesh D Parashar

“…Background Pneumococcal conjugate vaccine (PCV) and rotavirus vaccine (RV) are key tools for reducing common causes of infant mortality. …”
Get full text

Significant abundance of bacterial flagellin and expression of its surface localized receptor toll-like receptor 5 and cytokine interleukin-22 in South African infants with poor oral rotavirus vaccine take by Nontlantla J. Haindongo, Mapaseka Seheri, Cliff A. Magwira

Subjects: Get full text

The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis by Jonathan Carapetis, Tom Snelling, Mark A Jones, Julie A Marsh, Bianca Fleur Middleton, Claire S Waddington, Margaret Danchin, Carly McCallum, Sarah Gallagher, Ross Andrews, Carl Kirkwood, Nigel Cunliffe

“…Introduction Rotavirus vaccines were introduced into the Australian National Immunisation Program in 2007. …”
Get full text